Alexander Alschuler
Director, Global Regulatory Affairs Merck
Seminars
Wednesday 7th October 2026
Panel Discussion: Advancing Regulatory Frameworks & Standards for Compliant Digital Pathology Co-Development
3:10 pm
- How is the FDA dealing with staining, scanning and analysis in the CDx pathway?
- Foundation Models – how are we applying them and how far will we go?
- With reclassifications initiatives occurring, how can we follow this vain of policy and partnership evolution for digital pathology?
Thursday 8th October 2026
Drug Diagnostic Co-Development: Overlooked Challenges & Mitigations
12:20 pm
- Presenting examples and key considerations of scientific, operational and regulatory challenges
- Exploring process and workflow mitigations in drug-diagnostic co-development
